Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)
Clinical trial NCT04359654 · COMPLETED
Trial details
- NCT number
- NCT04359654
- Sponsor
- University College, London
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2021-08-12
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.